Showing codes J9002 (Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg) — J9044 (Injection, bortezomib, not otherwise specified, 0.1 mg)

J9002 - Doxil injection
Long description: Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
Code added date: 20130101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

J9010 - Alemtuzumab injection
Long description: Injection, alemtuzumab, 10 mg
Code added date: 20030101.
Code effective date: 20160101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

J9011 - Datopotamab deruxtecan, 1 mg
Long description: Injection, datopotamab deruxtecan-dlnk, 1 mg
Code added date: 20251001.
Code effective date: 20251001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9015 - Aldesleukin injection
Long description: Injection, aldesleukin, per single use vial
Code added date: 19960101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9017 - Arsenic trioxide injection
Long description: Injection, arsenic trioxide, 1 mg
Code added date: 20020101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9019 - Erwinaze injection
Long description: Injection, asparaginase (erwinaze), 1,000 iu
Code added date: 20130101.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9020 - Asparaginase, nos
Long description: Injection, asparaginase, not otherwise specified, 10,000 units
Code added date: 19840101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9021 - Inj, aspara, rylaze, 0.1 mg
Long description: Injection, asparaginase, recombinant, (rylaze), 0.1 mg
Code added date: 20220101.
Code effective date: 20220101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9022 - Inj, atezolizumab,10 mg
Long description: Injection, atezolizumab, 10 mg
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9023 - Injection, avelumab, 10 mg
Long description: Injection, avelumab, 10 mg
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9024 - Inj atezolizumb 5mg hya-tqjs
Long description: Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
Code added date: 20250401.
Code effective date: 20250401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9025 - Azacitidine injection
Long description: Injection, azacitidine, 1 mg
Code added date: 20060101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9026 - Inj, tarlatamab-dlle, 1 mg
Long description: Injection, tarlatamab-dlle, 1 mg
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9027 - Clofarabine injection
Long description: Injection, clofarabine, 1 mg
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9028 - Inj, nogapendekin pmln, 1mcg
Long description: Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
Code added date: 20250101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9029 - Instill adstiladrin, tx dose
Long description: Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
Code added date: 20230701.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9030 - Bcg live intravesical 1mg
Long description: Bcg live intravesical instillation, 1 mg
Code added date: 20190701.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9031 - Bcg live intravesical vac
Long description: Bcg (intravesical) per instillation
Code added date: 19910101.
Code effective date: 20190701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9032 - Injection, belinostat, 10mg
Long description: Injection, belinostat, 10 mg
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9033 - Inj, bendamustine hcl, 1mg
Long description: Injection, bendamustine hydrochloride, 1 mg
Code added date: 20090101.
Code effective date: 20250101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9034 - Inj., bendeka 1 mg
Long description: Injection, bendamustine hcl (bendeka), 1 mg
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9035 - Bevacizumab injection
Long description: Injection, bevacizumab, 10 mg
Code added date: 20050101.
Code effective date: 20050101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9036 - Inj. belrapzo/bendamustine
Long description: Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
Code added date: 20190701.
Code effective date: 20190701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9037 - Inj belantamab mafodot blmf
Long description: Injection, belantamab mafodotin-blmf, 0.5 mg
Code added date: 20210401.
Code effective date: 20250401.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9038 - Inj axatilimab-csfr 0.1 mg
Long description: Injection, axatilimab-csfr, 0.1 mg
Code added date: 20250401.
Code effective date: 20250701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9039 - Injection, blinatumomab
Long description: Injection, blinatumomab, 1 microgram
Code added date: 20160101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9040 - Bleomycin sulfate injection
Long description: Injection, bleomycin sulfate, 15 units
Code added date: 19840101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9041 - Injection, bortezomib, 0.1mg
Long description: Injection, bortezomib, 0.1 mg
Code added date: 20050101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9042 - Brentuximab vedotin inj
Long description: Injection, brentuximab vedotin, 1 mg
Code added date: 20130101.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9043 - Cabazitaxel injection
Long description: Injection, cabazitaxel, 1 mg
Code added date: 20120101.
Code effective date: 20120101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9044 - Inj, bortezomib, nos, 0.1 mg
Long description: Injection, bortezomib, not otherwise specified, 0.1 mg
Code added date: 20190101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF